Asthma
COPD
Pulmonary
Site Map
2026
July
23
Novel peptide could eliminate harmful inflammation at its source
Vitronectin opens door to novel PF therapies
Kinaset Therapeutics announces first patient dosing in phase 2b of severe asthma trial
Page 1 of 1